We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Molecular Electronics Close to Reality

By Biotechdaily staff writers
Posted on 18 Oct 2004
Silicon microelectronics has undergone a drastic miniaturization process during the past 30 years or so, leading to vast improvements in both speed and computational ability. More...
Now, however, researchers and engineers have been evaluating another exciting way to utilize individual molecules, as functional electronic devices.

A group of engineers at Northwestern University (Evanston, IL, USA) has become the first to accurately align multiple kinds of molecules on a silicon surface at room temperature--a significant step toward the reality of molecular electronics.

"We have demonstrated a strategy for intentionally positioning molecules, which is necessary for the construction of nanoscale systems such as molecular transistors or light-emitting diodes,” said Dr. Mark C. Hersam, assistant professor of materials science and engineering, who led the research team. "Our process works at room temperature and on silicon, which suggests that it can be made compatible with conventional silicon microelectronics. Ultimately, we want to integrate with current technology, thus creating a bridge between microelectronics and nanoelectronics.”

The data from the study show patterning on a magnitude of 10,000 times smaller than that of microelectronics. The study was published in the September 27, 2004, issue of the journal Applied Physics Letters (APL).

The nanofabrication method, called multistep feedback-controlled lithography, is useful for a host of essential studies and for the testing and building of prototype nanoscale devices that could be utilized in potential technologies ranging from biomedical diagnostics to consumer electronics.

"Previously we were working with single molecules on silicon,” said Dr. Hersam. "This new process enables us to build more complex structures. Plus, the technique is general and can be used with many different molecules, which increases its potential.”

The investigators verified their process by using a tailored ultrahigh-vacuum scanning tunneling microscope. With this technique, they created chains consisting of styrene and a molecule called TEMPO, and are now researching the electronic characteristics of this unique nanostructure.




Related Links:
Northwestern University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.